1. Home
  2. ORN vs STTK Comparison

ORN vs STTK Comparison

Compare ORN & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$15.81

Market Cap

555.4M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.96

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
STTK
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.4M
538.3M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
ORN
STTK
Price
$15.81
$4.96
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$16.25
$10.00
AVG Volume (30 Days)
336.1K
972.9K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
53.02
EPS
0.12
N/A
Revenue
$852,260,000.00
$1,000,000.00
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.83
N/A
P/E Ratio
$127.58
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.44
$0.71
52 Week High
$15.85
$8.33

Technical Indicators

Market Signals
Indicator
ORN
STTK
Relative Strength Index (RSI) 65.36 45.13
Support Level $13.20 $3.37
Resistance Level $15.83 $6.81
Average True Range (ATR) 0.74 0.58
MACD 0.15 0.05
Stochastic Oscillator 91.67 58.54

Price Performance

Historical Comparison
ORN
STTK

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: